Identification of Targets from LRRK2 Rescue Phenotypes

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Parkinson's disease (PD) is an age-related neurodegenerative disorder.
• Mutations in Leucine-rich repeat kinase 2 (LRRK2) are a primary genetic cause of PD.
• The function of LRRK2 protective variants in neurodegeneration remains unclear.

Purpose of the Study:

• To investigate the in vivo effects of LRRK2 protective variants (R1398H, N551K) and a pathogenic variant (G2019S) in Drosophila.
• To identify molecular pathways modulated by LRRK2 variants in dopaminergic neurons.
• To assess the potential of LRRK2 variants as therapeutic targets for PD.

Main Methods:

• Generation of transgenic Drosophila expressing wild-type, mutant, and variant LRRK2.
• RNA sequencing of dopaminergic neurons from different transgenic lines.
• Pathway enrichment analysis to identify modulated gene networks.

Main Results:

• LRRK2 protective variants suppressed phenotypic effects of the pathogenic G2019S mutation.
• RNA sequencing identified altered gene pathways, including actin cytoskeleton reorganization and oxidoreductase activity.
• Protective and rescue variants restored the induction of these pathways.

Conclusions:

• In vivo evidence supports the neuroprotective role of specific LRRK2 variants.
• LRRK2 variants modulate key cellular pathways relevant to PD pathogenesis.
• This study identifies potential therapeutic targets and a novel therapeutic strategy for PD.